biote Corp.

Biote Corp. (Nasdaq: BTMD) operates a high-growth practice-building business within the hormone optimization space, providing a comprehensive platform that enables healthcare practitioners to establish and operate profitable bioidentical hormone replacement therapy practices. The company's website is www.biote.com.

The Biote Method serves as the company's core offering, functioning similarly to a franchise model by providing practitioners with education, training, certification, practice management software, inventory management tools, and marketing support. The platform enables practitioners to treat patients experiencing hormonal imbalances associated with menopause, perimenopause, and andropause. As of December 31, 2025, Biote contracted with over 9,200 certified practitioners operating across more than 5,300 partnered clinics nationwide, with approximately 400,000 active patients and six million cumulative procedures performed.

The company generates revenue through two primary channels: procedure-based service fees from the Biote Method platform, which accounted for approximately 71 percent of revenue, and sales of Biote-branded dietary supplements, representing approximately 22 percent of revenue. The dietary supplement line comprises 26 products priced between $10 and $126.50, sold through both practitioner networks and direct-to-consumer channels. Approximately 65 percent of partnered clinics offer the dietary supplement products.

Biote's geographic footprint concentrates in ten core states including Texas, Florida, Colorado, Georgia, Alabama, Louisiana, Arkansas, Mississippi, Oklahoma, and New Mexico, which collectively generated approximately 53 percent of revenue as of 2025. The company maintains one national and four regional training facilities staffed with clinical faculty and medical advisors. The sales organization comprised 115 people as of December 31, 2025, including 108 commercial sales representatives.

Total revenue reached $192.2 million for the fiscal year ended December 31, 2025. The company maintains a practitioner retention rate exceeding 91 percent, reflecting high satisfaction with the platform. Biote's competitive positioning derives from its proprietary end-to-end platform, accretive practice economics for partnered clinics, established brand recognition among practitioners and patients, and experienced leadership team with extensive healthcare industry background.